Save time and get answers to complex questions with AI chat
Xiaflex market launch year?Somatuline depot patent expiry date?Combivent generic equivalent?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Dabrafenib mesylate when the patent is expiring in india?
See the DrugPatentWatch profile for Zoryve
Zoryve cream (ruxolitinib) is a topical JAK inhibitor. Most side effects are local to the skin where it’s applied. Common side effects (more likely, happen in a small percentage) - Redness or rash at the application site - Itching (pruritus) - Burning or stinging at the application site - Dry skin - Folliculitis (inflamed hair follicles) - Acne Other possible effects (less common) - Headache - Mild warmth or irritation at the treated area Serious but rare side effects (seek care promptly) - Signs of skin infection on the treated area (increasing redness, warmth, swelling, pus, fever) - Severe allergic reaction (rash with swelling of face/ lips/ tongue, trouble breathing) Practical notes - Do not apply to broken or severely irritated skin; avoid eyes, mouth, and nose. - Wash hands after applying; do not occlude the area unless your provider told you to. - If you notice anything unusual or persistent, or you suspect an infection, contact your clinician. If you’d like, I can tailor this to your situation (age, other meds, recent symptoms) or compare with Opzelura side effects.
Other Questions About Zoryve :